top of page
gradientForSurfBreak.png

Item List

May 3, 2022
PR Newswire
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received FDA Class II 510(k) clearance for home use of its first product, RESP®, which make this its second FDA clearance in less than 18 months.

Recent Posts

Portfolio Company

Carlsmed.png

Tombot Closes $7 Million Series A3 Growth Financing to Scale Operations and Expa ...

Businesswire

Jun 25, 2026

Portfolio Company

Carlsmed.png

Gradient Health Expands Atlas Beyond Imaging to Deliver Multimodal Data for Medi ...

Gradient

Jun 16, 2026

Portfolio Company

Carlsmed.png

Digital medical device for cancer detection certified for smartphone use ...

Med-Tech Insights

Jun 16, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page